Literature DB >> 12684014

Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme.

Michiyoshi Nukaga1, Kayoko Mayama, Andrea M Hujer, Robert A Bonomo, James R Knox.   

Abstract

Bacterial beta-lactamases hydrolyze beta-lactam antibiotics such as penicillins and cephalosporins. The TEM-type class A beta-lactamase SHV-2 is a natural variant that exhibits activity against third-generation cephalosporins normally resistant to hydrolysis by class A enzymes. SHV-2 contains a single Gly238Ser change relative to the wild-type enzyme SHV-1. Crystallographic refinement of a model including hydrogen atoms gave R and R(free) of 12.4% and 15.0% for data to 0.91 A resolution. The hydrogen atom on the O(gamma) atom of the reactive Ser70 is clearly seen for the first time, bridging to the water molecule activated by Glu166. Though hydrogen atoms on the nearby Lys73 are not seen, this observation of the Ser70 hydrogen atom and the hydrogen bonding pattern around Lys73 indicate that Lys73 is protonated. These findings support a role for the Glu166-water couple, rather than Lys73, as the general base in the deprotonation of Ser70 in the acylation process of class A beta-lactamases. Overlay of SHV-2 with SHV-1 shows a significant 1-3 A displacement in the 238-242 beta-strand-turn segment, making the beta-lactam binding site more open to newer cephalosporins with large C7 substituents and thereby expanding the substrate spectrum of the variant enzyme. The OH group of the buried Ser238 side-chain hydrogen bonds to the main-chain CO of Asn170 on the Omega loop, that is unaltered in position relative to SHV-1. This structural role for Ser238 in protein-protein binding makes less likely its hydrogen bonding to oximino cephalosporins such as cefotaxime or ceftazidime. Copyright 2003 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684014     DOI: 10.1016/s0022-2836(03)00210-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  51 in total

Review 1.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?

Authors:  Marisa L Winkler; Robert A Bonomo
Journal:  Mol Biol Evol       Date:  2015-11-03       Impact factor: 16.240

3.  Structural analysis of an "open" form of PBP1B from Streptococcus pneumoniae.

Authors:  Andrew L Lovering; Liza De Castro; Daniel Lim; Natalie C J Strynadka
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

4.  The acylation mechanism of CTX-M beta-lactamase at 0.88 a resolution.

Authors:  Yu Chen; Richard Bonnet; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2007-04-05       Impact factor: 15.419

Review 5.  Resistance to antibiotics targeted to the bacterial cell wall.

Authors:  I Nikolaidis; S Favini-Stabile; A Dessen
Journal:  Protein Sci       Date:  2014-01-17       Impact factor: 6.725

6.  High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.

Authors:  Pierre-Yves De Wals; Nicolas Doucet; Joelle N Pelletier
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

7.  β-Lactamase inhibition by 7-alkylidenecephalosporin sulfones: allylic transposition and formation of an unprecedented stabilized acyl-enzyme.

Authors:  Elizabeth A Rodkey; David C McLeod; Christopher R Bethel; Kerri M Smith; Yan Xu; Weirui Chai; Tao Che; Paul R Carey; Robert A Bonomo; Focco van den Akker; John D Buynak
Journal:  J Am Chem Soc       Date:  2013-12-03       Impact factor: 15.419

Review 8.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547

9.  An antibiotic-resistance enzyme from a deep-sea bacterium.

Authors:  Marta Toth; Clyde Smith; Hilary Frase; Shahriar Mobashery; Sergei Vakulenko
Journal:  J Am Chem Soc       Date:  2010-01-20       Impact factor: 15.419

10.  Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.

Authors:  Marisa L Winkler; Elizabeth A Rodkey; Magdalena A Taracila; Sarah M Drawz; Christopher R Bethel; Krisztina M Papp-Wallace; Kerri M Smith; Yan Xu; Jeffrey R Dwulit-Smith; Chiara Romagnoli; Emilia Caselli; Fabio Prati; Focco van den Akker; Robert A Bonomo
Journal:  J Med Chem       Date:  2013-02-04       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.